ERASCA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.89 USD | +2.16% |
|
-14.48% | -11.27% |
| 05-08 | Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-03 | North American Morning Briefing : Powell Awaited -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ERASCA, INC. | Other Biotechnology & Medical Research | +2.16% | -14.48% | -11.27% | -36.15% | - | 320M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ERAS Stock
- Charts Erasca, Inc.
- Comparison Chart